Werewolf Therapeutics Inc... (HOWL)
NASDAQ: HOWL
· Real-Time Price · USD
1.33
0.01 (0.76%)
At close: Aug 15, 2025, 3:59 PM
1.35
1.50%
After-hours: Aug 15, 2025, 05:47 PM EDT
Werewolf Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | -49K | 1.09M | 1.84M | 3.39M | 9.28M | 16.22M | 19.94M | 25.73M | 24.8M | 20.86M | 16.4M | 9.12M | 4.15M | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 1.8M | 2.25M | 2.29M | 1.83M | 1.82M | 2.14M | 1.68M | 1.78M | 2.04M | 15.15M | 15.63M | 15.13M | 14.67M | 1.01M | 735K | 676K | 437K | 205K |
Gross Profit | -1.85M | -1.16M | -454K | 1.55M | 7.46M | 14.08M | 18.27M | 23.95M | 22.76M | 5.71M | 767K | -6.02M | -10.52M | -1.01M | -735K | -676K | -437K | -205K |
Operating Income | -55.46M | -74.42M | -73.59M | -66.21M | -58.34M | -45.44M | -40.5M | -40.72M | -44.01M | -52.91M | -56.06M | -60.76M | -62.02M | -58M | -50.09M | -39.59M | -31.85M | -25.96M |
Interest Income | 4.75M | 5.7M | 6.67M | 7.57M | 7.84M | 8M | 7.54M | 6.52M | 5.24M | 3.39M | 1.91M | 744K | 205K | 159K | 137K | 132K | 78K | 51K |
Pretax Income | -73.14M | -72.41M | -70.52M | -62.12M | -53.73M | -41.58M | -37.37M | -37.3M | -40.95M | -50.45M | -53.81M | -59.75M | -61.56M | -57.89M | -49.98M | -39.52M | -31.83M | -18.65M |
Net Income | -73.14M | -72.41M | -70.52M | -62.12M | -53.73M | -41.58M | -37.37M | -36.05M | -39.11M | -48.23M | -51.56M | -58.75M | -61.16M | -57.87M | -49.98M | -39.52M | -31.83M | -18.65M |
Selling & General & Admin | 18.49M | 18.47M | 18.13M | 17.86M | 17.57M | 17.76M | 18.21M | 18.46M | 18.59M | 19.26M | 18.7M | 18.58M | 18.15M | 16.6M | 14.82M | 12.44M | 9.67M | 7.27M |
Research & Development | 54.52M | 56.65M | 56.43M | 50.36M | 48.67M | 42.98M | 41.78M | 47.99M | 50.22M | 54.52M | 53.76M | 51.3M | 48.02M | 41.4M | 35.27M | 27.16M | 22.18M | 18.7M |
Other Expenses | n/a | n/a | n/a | n/a | -445K | -470K | -470K | 779K | 1.23M | 1.53M | 1.53M | 299K | 296K | -1K | -17K | -70K | -70K | -54K |
Operating Expenses | 73M | 75.11M | 74.56M | 68.22M | 65.8M | 60.29M | 59.54M | 66M | 68.81M | 73.78M | 72.46M | 69.88M | 66.17M | 58M | 50.09M | 39.59M | 31.85M | 25.96M |
Interest Expense | 2.47M | 4.92M | 4.66M | 4.63M | 4.28M | 4.1M | 3.27M | 2.03M | 1.13M | 172K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | -454K | -918K | -1.38M | -1.38M | -924K | -460K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 55.46M | 75.57M | 75.48M | 69.59M | 67.62M | 61.66M | 60.45M | 66.44M | 68.81M | 73.78M | 72.46M | 69.88M | 66.17M | 58M | 50.09M | 39.59M | 31.85M | 25.96M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.25M | -1.84M | -2.22M | -2.25M | -1.04M | -449K | -122K | -132K | -112K | -112K | -61K |
Shares Outstanding (Basic) | 44.98M | 44.83M | 44.48M | 43.7M | 43.52M | 41.61M | 36.57M | 35.65M | 35.56M | 34.78M | 30.73M | 29.76M | 27.52M | 27.39M | 27.27M | 27.19M | 17.75M | 26.29M |
Shares Outstanding (Diluted) | 44.98M | 44.83M | 44.48M | 43.7M | 43.52M | 41.61M | 36.57M | 35.65M | 35.56M | 34.78M | 30.73M | 29.76M | 27.52M | 27.39M | 27.27M | 27.19M | 17.75M | 26.29M |
EPS (Basic) | -1.64 | -1.64 | -1.63 | -1.5 | -1.35 | -1.09 | -1.04 | -1.06 | -1.21 | -1.59 | -1.81 | -2.12 | -2.25 | -2.35 | -2.07 | -2.24 | -2.41 | -1.54 |
EPS (Diluted) | -1.64 | -1.64 | -1.63 | -1.5 | -1.35 | -1.09 | -1.04 | -1.06 | -1.21 | -1.59 | -1.81 | -2.12 | -2.25 | -2.35 | -2.07 | -2.24 | -2.41 | -1.54 |
EBITDA | -50.07M | -65.72M | -64.05M | -55.66M | -49.49M | -38.16M | -34.82M | -37.28M | -40.61M | -51.07M | -54.95M | -60M | -61.59M | -57.7M | -49.84M | -39.38M | -31.67M | -25.8M |
EBIT | -51.39M | -67.5M | -65.86M | -57.49M | -51.31M | -40.3M | -36.92M | -39.34M | -42.63M | -52.5M | -56.06M | -60.76M | -62.02M | -58M | -50.09M | -39.59M | -31.85M | -25.96M |
Depreciation & Amortization | 1.32M | 1.78M | 1.81M | 1.83M | 1.82M | 2.14M | 2.1M | 2.2M | 2.46M | 2.45M | 2.51M | 2.01M | 1.54M | 1.01M | 735K | 720K | 522K | 332K |